
51 - 200 employees
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Celcuity is a clinical-stage biotechnology company developing targeted therapies that block the PI3K/AKT/mTOR (PAM) pathway to treat multiple solid tumors. Its lead candidate, gedatolisib, is a potential first-in-class pan-PI3K and mTORC1/2 inhibitor being evaluated in breast and prostate cancer trials. The company advances a focused pipeline aimed at delivering transformative, targeted cancer treatments and conducts clinical development and data-driven research to support regulatory and medical adoption.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 September 23
Formulation scientist leading development and scale-up of Celcuity’s targeted oncology drug products. Supporting outsourced experiments, regulatory filings, and lifecycle management.
🇺🇸 United States – Remote
💵 $150k - $175k / year
⏰ Full Time
🟠 Senior
🧬 Research Scientist
👻 Ghost score 2%
🕒 September 22
Patient marketing leader launching Celcuity’s REVTORPYK oncology therapy. Developing patient, caregiver, and APP promotional strategies for advanced breast cancer.
🕒 September 21
Associate Director leading strategic oncology congress planning for Celcuity, a commercial biotechnology company developing targeted cancer therapies. Overseeing exhibits, vendors, budgets, logistics, and onsite event execution.
🕒 August 31
Statistical programming manager overseeing SAS, CDISC, SDTM, ADaM, and TLF deliverables for Celcuity’s targeted cancer therapies. Supporting clinical studies, regulatory submissions, and CRO programming oversight.
🕒 August 25
Senior Director leading analytical development, CMC methods, and stability programs for Celcuity’s targeted cancer therapies. Overseeing CDMOs and supporting commercial pharmaceutical assets.
🕒 August 21
Commercial supply operations leader supporting Celcuity’s oncology drug manufacturing and global supply chain. Driving compliant production planning, launches, external partnerships, and supply processes.